ENDOMETRIAL CARCINOMA - STEROID-RECEPTORS AND RESPONSE TO MEDROXYPROGESTERONE ACETATE

被引：58

作者：

QUINN, MA

CAUCHI, M

FORTUNE, D

机构：

[1] ROYAL WOMENS HOSP,DEPT PATHOL,MELBOURNE,AUSTRALIA

[2] ROYAL WOMENS HOSP,DEPT HAEMATOL,MELBOURNE,AUSTRALIA

来源：

GYNECOLOGIC ONCOLOGY | 1985年 / 21卷 / 03期

关键词：

D O I：

10.1016/0090-8258(85)90269-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：314 / 319

页数：6

共 23 条

[1] DO ESTROGEN AND PROGESTERONE RECEPTORS (E2R AND PR) IN METASTASIZING ENDOMETRIAL CANCERS PREDICT THE RESPONSE TO GESTAGEN THERAPY [J].

BENRAAD, TJ ;

FRIBERG, LG ;

KOENDERS, AJM ;

KULLANDER, S .

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1980, 59 (02) :155-159

[2] HORMONO-PROPHYLAXIS AND HORMONOTHERAPY IN TREATMENT OF ENDOMETRIAL ADENOCARCINOMA BY MEANS OF MEDROXYPROGESTERONE ACETATE [J].

BONTE, J ;

DECOSTER, JM ;

IDE, P ;

BILLIET, G .

GYNECOLOGIC ONCOLOGY, 1978, 6 (01) :60-75

[3]

BONTE J, 1973, ENDOMETRIAL CANCER, P203

[4]

BRIGGS MH, 1967, HOSP MED, V2, P63

[5]

COFFIER H, 1982, P INT S MEDROXYPROGE, P389

[6] CLINICAL CORRELATES OF ESTROGEN-BINDING AND PROGESTERONE-BINDING PROTEINS IN HUMAN ENDOMETRIAL ADENOCARCINOMA [J].

CREASMAN, WT ;

MCCARTY, KS ;

BARTON, TK ;

MCCARTY, KS .

OBSTETRICS AND GYNECOLOGY, 1980, 55 (03) :363-370

[7]

EHRLICH CE, 1978, ENDOMETRIAL CANCER, P258

[8]

GEISLER H E, 1973, Gynecologic Oncology, V1, P340, DOI 10.1016/0090-8258(73)90026-7

[9] 17ALPHA-HYDROXYPROGESTERONE CAPROATE TREATMENT OF GYNECOLOGIC CANCER [J].

HRESHCHYSHYN, MM ;

GRAHAM, RM .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1969, 104 (06) :916-+

[10] STEROID-HORMONE RECEPTORS IN ADENOCARCINOMA OF THE ENDOMETRIUM [J].

HUNTER, RE ;

LONGCOPE, C ;

JORDAN, VC .

GYNECOLOGIC ONCOLOGY, 1980, 10 (02) :152-161

← 1 2 3 →